Trisoprim

Quick links to important sections

Trisoprim

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Trisoprim

Trisoprim is a synthetic, prescription-only medicine classified as a potent systemic antimicrobial agent designed to control and eliminate bacterial infections throughout the body.

Quick Facts

Property Description
Active ingredient Trimethoprim and Sulfadiazine Silver
Form Fixed-dose oral preparation (e.g., tablet)
Pharmacological class Antibiotic
Common use Elimination of bacterial infections
Origin Synthetic compound

What Type of Medicine is Trisoprim?

Trisoprim is a fixed-dose combination (FDC) antibiotic utilizing a dual-action approach that is clinically recognized for its reliable efficacy in systemic therapy. The drug's active components are synthetic compounds, meaning they are chemically manufactured rather than derived from natural sources, which ensures high purity and reliable potency. Its established structure as an FDC places it among combinations where the combined therapeutic effect is intended to be significantly enhanced by the synergistic action of its two components.


Composition and Chemical Origin

The active ingredients in Trisoprim are Trimethoprim and Sulfadiazine Silver, which originate from two different chemical families—a unique feature that differentiates its broad-spectrum action. Trimethoprim is categorized as a diaminopyrimidine derivative, while Sulfadiazine Silver is a potent combination of a sulfonamide and a silver salt. This intentional pairing creates a coordinated chemical action known as synergism, meaning the combined effect is much stronger than the sum of their individual actions. This pairing is a highly effective pharmacological strategy used to manage bacterial organisms.


What is the General Purpose of This Combination?

The primary general purpose of Trisoprim is to serve as a robust antimicrobial tool for eliminating or controlling systemic bacterial overgrowth, such as in instances of acute infectious processes. The dual components achieve this by executing a sequential blockade of the bacterial folate pathway, which contains the fundamental processes necessary for the pathogen’s growth and replication. The therapeutic goal is to apply this powerful, synergistic intervention to successfully clear the underlying infection and restore the patient to health by neutralizing bacterial proliferation, a mechanism relied upon in the treatment of various bacterial ailments.

What side effects are possible with Trisoprim?

Possible Side Effects and Safety Information

The safety profile of Trisoprim, a systemic antimicrobial agent, is based on official government regulatory documents (e.g., FDA, EMA) for the Trimethoprim-Sulfonamide class. Adverse reactions are classified by frequency and affected body system.

Frequency and System-Organ Classes

The regulatory label identifies side effects spanning several systems, including Blood and Lymphatic, Skin, Gastrointestinal, Nervous System, and Hepatobiliary. Hyperkalemia (high blood potassium) is classified as Very Common (ge 1/10). Reactions such as nausea, vomiting, diarrhea, skin rash, and headache are generally classified as Common (ge 1/100).

Serious Adverse Reactions

Official labeling documents identify several rare but serious adverse reactions. These include Severe Cutaneous Adverse Reactions (SCARs) such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), which can be fatal. Other critical risks are severe blood disorders (e.g., Agranulocytosis or Aplastic Anemia) and Fulminant Hepatic Necrosis.

Safety Restrictions and Vulnerable Populations

Trisoprim is subject to several absolute restrictions as defined by regulatory agencies. It is contraindicated in infants less than two months of age, during pregnancy, and while breastfeeding due to potential serious risk. It is also restricted for use in patients with severe liver or kidney disease and those with documented megaloblastic anemia due to folate deficiency. A specific warning notes that the highest risk for SCARs occurs within the first few weeks of treatment, necessitating discontinuation at the first appearance of a rash.

Overdose and Emergency Response

The official regulatory profile for Trisoprim overdose describes manifestations that typically involve the gastrointestinal and neurological systems, such as nausea, vomiting, headache, and confusion. Overdose is officially classified as a potentially severe, life-threatening scenario due to the documented risk of serious systemic outcomes.

Documented Severe Outcomes

Severe or life-threatening manifestations noted in official labeling include circulatory shock, severe hypotension, and hepatic necrosis. The regulatory information also highlights the risk of severe cutaneous adverse reactions (SCARs), such as Stevens-Johnson syndrome, and serious hematologic toxicity, including agranulocytosis.

When to Seek Immediate Help

Government regulatory authorities mandate that individuals seek immediate medical attention upon any suspected overdose. Emergency services must be contacted immediately for any severe symptoms, including signs of passing out or difficulty breathing, which can indicate life-threatening systemic compromise.

Management and Population Risk

No specific antidote is known for Trisoprim overdose. Consequently, management officially involves symptomatic and supportive care, which may include the administration of Folinic Acid to mitigate the risk of bone marrow suppression. Special consideration is given to populations with severely impaired renal function and individuals with G6PD deficiency, who are at increased risk for heightened toxicity or specific adverse hematologic reactions, as stated in the prescribing information.

Therapeutic Uses of Trisoprim

What Trisoprim Treats: Main Uses and Benefits

Trisoprim (a systemic therapeutic agent) is applied across several key therapeutic domains and is generally used in situations involving certain distressing symptoms. It provides support that helps ease the overall burden of acute symptoms and contributes to improved comfort. The combination is generally used for a broad range of conditions associated with acute or disruptive episodes.


The medication is commonly used for conditions where symptoms may intensify temporarily, specifically helping to manage symptoms in Genitourinary Tract Infections (such as UTIs and pyelonephritis), acute exacerbations of chronic bronchitis, and specific Gastrointestinal Distress (like severe bacterial diarrhea). It is also considered relevant in situations involving recurrent or episodic manifestations of certain severe infections, such as Pneumocystis Jirovecii Pneumonia (PJP) and Toxoplasmosis, particularly in vulnerable populations.

In these contexts, the core benefit contributes to easing the overall symptom load, which helps manage distressing manifestations that interfere with daily stability and supports general well-being during symptomatic phases.

Quick Fact: Relief for Acute Symptoms
Patient-Oriented Benefit Helps ease symptoms related to physical discomfort, such as painful urination (dysuria) and acute gastrointestinal distress.
Clinical Scenarios Often applied in clinical settings that involve acute or unstable symptom patterns, such as flare-ups of chronic conditions.

Regulatory References

  1. NIH StatPearls on Trimethoprim/Sulfamethoxazole

Eligibility and Restrictions for Use

Who can and cannot use Trisoprim?

Eligibility for Trisoprim (a systemic Trimethoprim/Sulfonamide) is strictly defined by regulatory bodies based on age, allergies, and specific underlying conditions.


Contraindicated Populations (Must Not Use)

Contraindication Basis for Restriction
Allergy to Components Known hypersensitivity to Trimethoprim or Sulfonamides (sulfa drugs).
Severe Organ Damage Marked hepatic damage or severe renal insufficiency when function cannot be monitored.
Infants Pediatric patients under two months of age due to the risk of kernicterus.
Pregnancy/Lactation Pregnant women at term and nursing mothers.
Blood/Folate Disorders Documented megaloblastic anemia due to folate deficiency.

Restricted or Conditional Use

Certain populations may use Trisoprim only with caution and close monitoring, as noted in official prescribing information.

  • Older Adults: Use requires caution due to an increased risk of adverse reactions, including hyperkalemia and folate deficiency.
  • Genetic Conditions: Patients with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency or Porphyria must be closely monitored.
  • Non-Severe Impairment: Individuals with non-severe liver or kidney disease are eligible but require dosage adjustments and monitoring.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Trisoprim (Trimethoprim/Sulfadiazine Silver) describes several interaction patterns that affect the concentration or physiological action of co-administered substances.

Pharmacokinetic and Transporter Interactions

Trisoprim is documented to alter the plasma levels of several medicines. Co-administration potentiates the anticoagulant effect of Warfarin and increases the half-life of Phenytoin. The Trimethoprim component also interferes with the renal clearance of substances like Metformin, Amantadine, and Memantine, specifically through competition at the Organic Cation Transporter 2 (OCT2), leading to higher plasma concentrations. Additionally, Digoxin blood levels may be increased, an effect noted as more significant in elderly patients.

Pharmacodynamic and Restriction-Based Interactions

The simultaneous use of Trisoprim with ACE Inhibitors or Diuretics (e.g., Spironolactone) carries a documented additive risk of hyperkalemia (elevated serum potassium). An additive anti-folate effect is noted with Pyrimethamine at high doses, risking megaloblastic anemia. The official regulatory label states that co-administration with Dofetilide is formally contraindicated. Use of the drug with Alcohol (Ethanol) may result in a severe disulfiram-like reaction.

Mechanism of Action

How Trisoprim Works

Trisoprim uses a dual-action mechanism targeting the bacterial folate synthesis pathway. Its effect is derived from the sequential blockade of a microbial pathway essential for genetic material production. The mechanism utilizes a pathway that is structurally distinct from human metabolic processes.


Enzyme-Mediated Metabolic Starvation

This domain covers the drug’s primary molecular targets and the resulting metabolic cascade. The two components, Sulfadiazine and Trimethoprim, act as inhibitors on two consecutive enzymes—Dihydropteroate Synthase (DHPS) and Dihydrofolate Reductase (DHFR)—within the bacterial folate synthesis pathway. This action arrests the conversion of simple precursors into the complex cofactors needed for the cell to build its DNA and RNA.


Synergistic Shift to Bactericidal Action

This domain explains the magnified physiological consequence of the drug’s combined activity. The sequential, double-hit inhibition creates a synergistic effect that is amplified compared to the action of the individual components, leading to a rapid, severe depletion of essential purines and thymidines. This mechanistic shift results in a bactericidal (cell-killing) action, leading to the destruction of the bacterial cells rather than a bacteriostatic halt to their growth.

Dosage and Administration Information

How to Use Trisoprim

Trisoprim (Trimethoprim/Sulfonamide FDC) is administered according to specific, standardized instructions to ensure proper use and systemic effect. These guidelines address the route, frequency, duration, and patient-specific adjustments.


Official Routes and Dosage Schedules

Trisoprim is approved for two primary administration routes: Oral (as tablets or suspension) and Intravenous (IV) Infusion. The choice of route and dose depends on the severity of the condition.

Administration Detail Standard Adult Regimen Special Condition Regimen
Standard Oral Dose One Double Strength (DS) Tablet (160 mg Trimethoprim / 800 mg Sulfonamide) every 12 hours. N/A
Severe Infection Dose Weight-adjusted based on Trimethoprim: 15 to 20 mg/kg/day in equally divided doses, typically every 6 to 8 hours. N/A
Max Daily Dose 960 mg (Trimethoprim component). N/A

Administration Requirements and Duration

Oral Administration: Tablets may be taken without regard to meals but should be consumed with a full glass of water.

IV Administration: The intravenous concentrate must be diluted prior to use and administered as a slow infusion over 60 to 90 minutes. It must not be given as a rapid injection or intramuscularly.

Treatment Duration: The required length of therapy varies: a short course may be 5 days, while common infections require 10 to 14 days. Treatment for severe infections, such as PJP, typically extends to 14 to 21 days.

Population-Specific Use

Dosage adjustments are required for certain populations:

  • Renal Impairment: The dosage must be reduced by 50% when creatinine clearance (CrCl) is between 15 and 30 mL/min. Use is generally not recommended below 15 mL/min.
  • Pediatric Patients: The medicine is not recommended for use in infants under 2 months of age.

Recent Clinical Evidence

Trisoprim is a brand name for the antibiotic trimethoprim, which is primarily used to treat and prevent bacterial infections. Clinically, trimethoprim is often used alone for uncomplicated urinary tract infections (UTIs) caused by susceptible bacteria such as E. coli, Proteus mirabilis, and certain Staphylococcus species, or in combination with sulfamethoxazole as co-trimoxazole.

Efficacy and Resistance

Recent clinical data affirm trimethoprim's effectiveness in short-course regimens (typically three days) for uncomplicated cystitis in regions with low rates of bacterial resistance. However, a major focus of current research and clinical guidelines revolves around antimicrobial resistance to the drug. The prevalence of trimethoprim-resistant E. coli—a key uropathogen—varies geographically. In areas where resistance to the trimethoprim/sulfamethoxazole combination is known to exceed 20%, it is not recommended as an empiric (initial) treatment choice for uncomplicated UTIs.

Patient Populations and Dosing

Studies have also explored the use of the combined therapy (trimethoprim/sulfamethoxazole) in critically ill patients, particularly those on renal replacement therapies, who face complex infections like those caused by Stenotrophomonas maltophilia. Research in this area suggests that conventional dosing for these patient groups may be associated with high rates of clinical failure, highlighting the need for careful dose adjustments based on individual patient factors and kidney function to ensure therapeutic drug concentrations.

Furthermore, because the drug is excreted primarily by the kidneys, there is an increased risk of side effects, such as hyperkalemia (elevated potassium levels) and acute kidney injury, particularly in older patients or those with pre-existing kidney conditions. Healthcare providers must monitor these risks, especially during treatment for recurrent UTIs.

Frequently Asked Questions (FAQ)

Common questions about Trisoprim (FAQ)

Q: What kind of medical conditions is Trisoprim typically used to manage?

According to official regulatory documents, this medicine is primarily used to treat infections caused by susceptible bacteria. These typically include certain urinary tract infections (UTIs), acute otitis media (a type of ear infection), and certain types of severe pneumonia like Pneumocystis jirovecii pneumonia (PJP).


Q: What are the most common reasons doctors prescribe Trisoprim?

The official prescribing information states that this combination medicine is commonly used to treat bacterial infections. These typically involve conditions like certain urinary tract infections (UTIs), acute ear infections (otitis media), and specific serious infections like Pneumocystis jirovecii pneumonia (PJP).


Q: What are the official warnings listed for Trisoprim?

The regulatory label contains serious warnings regarding rare but potentially fatal reactions. These include severe skin reactions, such as Stevens-Johnson Syndrome, serious blood disorders like agranulocytosis, and acute liver injury. Official information states that the medicine should be discontinued immediately if a rash develops.


Q: Is Trisoprim the same as Trimethoprim?

Official drug descriptions clarify that Trisoprim is a brand name for a combination of two active ingredients: trimethoprim and a sulfonamide component (such as sulfamethoxazole or sulfadiazine). Therefore, Trisoprim is a fixed-dose combination product and is not the same as trimethoprim taken alone.


Q: Is it possible to have a delayed reaction to Trisoprim?

Regulatory information indicates that the risk for certain severe skin reactions (SCARs) is highest during the first few weeks of treatment. However, these serious reactions have been reported to occur up to several months after beginning treatment.


Q: Is Trisoprim considered safe for children?

Official regulatory guidelines indicate that this medicine is formally contraindicated in infants under two months of age due to specific health risks. For children older than two months, the dosage is determined by the healthcare provider based on the child's weight and the specific infection being treated.


Q: Does taking Trisoprim require any special monitoring like blood tests?

Yes, regulatory documents state that regular laboratory tests may be required during treatment. This monitoring commonly includes complete blood counts and checks on blood potassium levels. Such monitoring is particularly important for patients receiving long-term treatment or those with pre-existing impaired kidney function.


Q: What is the generic name for Trisoprim?

Trisoprim is a brand name. The generic name for the combination drug typically found in this medicine is sulfamethoxazole and trimethoprim, often referred to as co-trimoxazole.


Q: How quickly does Trisoprim start working after taking it?

Clinical pharmacology information indicates that the active components are absorbed rapidly following oral administration. Peak blood levels, which are generally associated with the start of the drug's effect, are typically reached 1 to 4 hours after taking a dose.


Q: How long does Trisoprim stay in the system?

Studies show that the two active components have mean serum half-lives of approximately 8 to 10 hours and 10 hours, respectively. Detectable amounts of the components are typically present in the blood up to 24 hours after a single administration.


Q: Why do people sometimes call Trisoprim by a different name?

It is common for prescription medicines to have multiple names. Trisoprim is a brand name, but the drug is also known by its generic name (sulfamethoxazole and trimethoprim) or by other brand names used by different manufacturers.


Q: Is it common to feel dizzy or lightheaded while taking Trisoprim?

Regulatory documents list dizziness as a possible side effect of this medicine. Official information notes that this may impact a patient's ability to perform normal activities, and monitoring for this effect is suggested.


Q: Is it safe to take Trisoprim with over-the-counter pain relievers like ibuprofen?

Regulatory information does not specifically list an interaction with over-the-counter pain relievers such as ibuprofen. However, the prescribing information mentions the potential for increased risk when combined with drugs that can increase the risk of high potassium levels (hyperkalemia) or negatively affect kidney function.


Q: Are there any dietary restrictions or foods to avoid while on Trisoprim?

The official administration guidelines state that the medicine can generally be taken without regard to meals. However, Official information notes that patients identified as being at risk for high potassium levels (hyperkalemia) may need to monitor their intake of high-potassium foods.


Q: Can Trisoprim affect the way birth control pills work?

Studies reviewed by regulatory bodies generally indicate that this medicine does not reduce the effectiveness of hormonal contraceptives, such as birth control pills, the patch, or the ring.


Q: What happens if I miss a dose of Trisoprim?

Patient information outlines that a missed dose is typically taken as soon as it is remembered. However, if the time is close to the next scheduled dose, the regulatory guidance is often to skip the missed dose. Official guidelines caution against taking double or extra doses to compensate.


Q: What happens if I take too much Trisoprim?

Regulatory documents describe that an acute overdose may lead to symptoms such as nausea, vomiting, mental confusion, fever, and the presence of blood in the urine. In the event of a suspected overdose, it is necessary to contact emergency medical services immediately.


Q: Is Trisoprim a controlled substance?

This medicine is not classified as a federally controlled substance by the US Drug Enforcement Administration (DEA). This means it is not associated with the regulatory scheduling meant to control drugs with high abuse or dependence potential.


Q: Is there long-term data available for Trisoprim use?

While detailed long-term efficacy data is not typically summarized for the general public, the regulatory label notes that close monitoring is required for patients on prolonged or chronic use. This monitoring is necessary due to the increased risk of certain adverse events, such as blood disorders.


Q: Will Trisoprim affect my ability to drive or operate machinery?

Side effects that impact the central nervous system, such as dizziness, headache, or confusion, are reported in official documents. Due to these potential effects, the official label includes a warning regarding driving or operating machinery until it is established how the medicine affects the individual.


Q: What is the risk of becoming dependent on Trisoprim?

Because this medicine is not classified as a controlled substance, regulatory agencies do not consider it to have known abuse or dependence potential.


Q: Is there a known association between Trisoprim and sun sensitivity?

Yes, official patient information confirms that this medicine can cause the skin to be more sensitive to the sun (a condition known as photosensitivity). Given this risk, official materials recommend protective measures, such as using clothing and sunscreen, when there is sun exposure.


Q: Can Trisoprim affect blood sugar levels?

Regulatory documents indicate that this medicine can affect blood glucose levels. It can interact with and potentiate the effects of certain oral hypoglycemic medicines, and, rarely, cause low blood sugar (hypoglycemia) even in non-diabetic patients.


Q: Where can I find the official prescribing information for Trisoprim?

The complete and official prescribing information (known as the FDA Label in the US or Summary of Product Characteristics/SmPC in Europe) can typically be found on the websites of the relevant governmental regulatory body in the country of purchase. These sources are the original reference for all official drug information.


Q: What should I do if my symptoms worsen while on Trisoprim?

Official patient information states that a healthcare provider must be contacted immediately if symptoms do not improve or if they worsen. This worsening may be a sign that the medicine is not working or that a new infection has developed.


Q: Can Trisoprim interact with vitamins or supplements?

This medicine acts as a folate antagonist, which means it interferes with the body's folate pathway. Therefore, official regulatory documents note that combining it with high doses of folic acid supplements or other compounds that interact with the folate pathway may potentially affect its action.

How should Trisoprim be stored and disposed of?

Storage and Disposal Conditions for Trisoprim (Sulfamethoxazole/Trimethoprim)

Official regulatory documents define specific storage and disposal requirements for this medication to maintain its integrity and ensure safety.


Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature (20 C to 25 C).
Protection Keep protected from light, excessive heat, and moisture.
Prohibitions The medication must not be frozen, and tablets should not be refrigerated.
Container Keep the medicine in a tightly closed, light-resistant container.
Child Safety Store the product out of the reach and sight of children.

Disposal Instructions

Unused or expired Trisoprim should be disposed of according to official guidelines. The preferred method is using an authorized drug take-back program. If a take-back program is unavailable, the medication may be discarded in the household trash after being mixed with an unappealing substance like used coffee grounds and sealed in a container. The medication must not be flushed down a toilet or sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Trisoprim found in:

A-Z Index: